ID   TGFR2_HUMAN             Reviewed;         592 AA.
AC   P37173-2;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   12-OCT-2022, entry version 243.
DE   RecName: Full=Isoform 2 of TGF-beta receptor type-2;
DE            Short=TGFR-2;
DE            EC=2.7.11.30;
DE   AltName: Full=TGF-beta type II receptor;
DE   AltName: Full=Transforming growth factor-beta receptor type II;
DE            Short=TGF-beta receptor type II;
DE            Short=TbetaR-II;
DE   Flags: Precursor;
GN   Name=TGFBR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ALA-439, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Liver;
RX   PubMed=1310899; DOI=10.1016/0092-8674(92)90152-3;
RA   Lin H.Y., Wang X.-F., Ng-Eaton E., Weinberg R.A., Lodish H.F.;
RT   "Expression cloning of the TGF-beta type II receptor, a functional
RT   transmembrane serine/threonine kinase.";
RL   Cell 68:775-785(1992).
RN   [2]
RP   ERRATUM OF PUBMED:1310899.
RX   PubMed=1525823;
RA   Lin H.Y., Wang X.-F., Ng-Eaton E., Weinberg R.A., Lodish H.F.;
RL   Cell 70:1069-1069(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Glial cell;
RX   PubMed=7959019; DOI=10.1016/0378-1119(94)90178-3;
RA   Nikawa J.;
RT   "A cDNA encoding the human transforming growth factor beta receptor
RT   suppresses the growth defect of a yeast mutant.";
RL   Gene 149:367-372(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT ALA-439.
RX   PubMed=8812462; DOI=10.1006/geno.1996.0471;
RA   Takenoshita S., Hagiwara K., Nagashima M., Gemma A., Bennett W.P.,
RA   Harris C.C.;
RT   "The genomic structure of the gene encoding the human transforming growth
RT   factor beta type II receptor (TGF-beta RII).";
RL   Genomics 36:341-344(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT ALA-439.
RX   PubMed=8840968;
RA   Lu S.-L., Zhang W.C., Akiyama Y., Nomizu T., Yuasa Y.;
RT   "Genomic structure of the transforming growth factor beta type II receptor
RT   gene and its mutations in hereditary nonpolyposis colorectal cancers.";
RL   Cancer Res. 56:4595-4598(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-439.
RC   TISSUE=Liver;
RX   PubMed=8973329; DOI=10.1016/s0378-1119(96)00501-x;
RA   Ogasa H., Noma T., Murata H., Kawai S., Nakazawa A.;
RT   "Cloning of a cDNA encoding the human transforming growth factor-beta type
RT   II receptor: heterogeneity of the mRNA.";
RL   Gene 181:185-190(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION (ISOFORM 3), SUBUNIT
RP   (ISOFORM 3), AND SUBCELLULAR LOCATION (ISOFORM 3).
RC   TISSUE=Peripheral blood T-cell {ECO:0000303|PubMed:34568316};
RX   PubMed=34568316; DOI=10.3389/fcell.2021.690397;
RA   Bertolio M.S., La Colla A., Carrea A., Romo A., Canziani G., Echarte S.M.,
RA   Campisano S., Barletta G.P., Monzon A.M., Rodriguez T.M., Chisari A.N.,
RA   Dewey R.A.;
RT   "A Novel Splice Variant of Human TGF-beta Type II Receptor Encodes a
RT   Soluble Protein and Its Fc-Tagged Version Prevents Liver Fibrosis in
RT   vivo.";
RL   Front. Cell Dev. Biol. 9:690397-690397(2021).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-36.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 23-37.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF TGFBR1.
RX   PubMed=7774578; DOI=10.1002/j.1460-2075.1995.tb07214.x;
RA   Wieser R., Wrana J.L., Massague J.;
RT   "GS domain mutations that constitutively activate T beta R-I, the
RT   downstream signaling component in the TGF-beta receptor complex.";
RL   EMBO J. 14:2199-2208(1995).
RN   [13]
RP   INTERACTION WITH CLU.
RX   PubMed=8555189; DOI=10.1021/bi951880a;
RA   Reddy K.B., Karode M.C., Harmony A.K., Howe P.H.;
RT   "Interaction of transforming growth factor beta receptors with
RT   apolipoprotein J/clusterin.";
RL   Biochemistry 35:309-314(1996).
RN   [14]
RP   ALTERNATIVE SPLICING (ISOFORM 2), AND FUNCTION (ISOFORMS 1 AND 2).
RX   PubMed=8635485; DOI=10.1006/excr.1996.0066;
RA   Hirai R., Fijita T.;
RT   "A human transforming growth factor-beta type II receptor that contains an
RT   insertion in the extracellular domain.";
RL   Exp. Cell Res. 223:135-141(1996).
RN   [15]
RP   INTERACTION WITH ZFYVE9.
RX   PubMed=9865696; DOI=10.1016/s0092-8674(00)81701-8;
RA   Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., Wrana J.L.;
RT   "SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.";
RL   Cell 95:779-791(1998).
RN   [16]
RP   HOMODIMERIZATION.
RX   PubMed=9472030; DOI=10.1083/jcb.140.4.767;
RA   Gilboa L., Wells R.G., Lodish H.F., Henis Y.I.;
RT   "Oligomeric structure of type I and type II transforming growth factor beta
RT   receptors: homodimers form in the ER and persist at the plasma membrane.";
RL   J. Cell Biol. 140:767-777(1998).
RN   [17]
RP   INTERACTION WITH DAXX, AND MUTAGENESIS OF LYS-277.
RX   PubMed=11483955; DOI=10.1038/35087019;
RA   Perlman R., Schiemann W.P., Brooks M.W., Lodish H.F., Weinberg R.A.;
RT   "TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that
RT   facilitates JNK activation.";
RL   Nat. Cell Biol. 3:708-714(2001).
RN   [18]
RP   INTERACTION WITH VPS39.
RX   PubMed=12941698; DOI=10.1093/emboj/cdg428;
RA   Felici A., Wurthner J.U., Parks W.T., Giam L.R., Reiss M., Karpova T.S.,
RA   McNally J.G., Roberts A.B.;
RT   "TLP, a novel modulator of TGF-beta signaling, has opposite effects on
RT   Smad2- and Smad3-dependent signaling.";
RL   EMBO J. 22:4465-4477(2003).
RN   [19]
RP   INTERACTION WITH DYNLT4.
RX   PubMed=16982625; DOI=10.1074/jbc.m608614200;
RA   Meng Q.-J., Lux A., Holloschi A., Li J., Hughes J.M.X., Foerg T.,
RA   McCarthy J.E.G., Heagerty A.M., Kioschis P., Hafner M., Garland J.M.;
RT   "Identification of Tctex2beta, a novel dynein light chain family member
RT   that interacts with different transforming growth factor-beta receptors.";
RL   J. Biol. Chem. 281:37069-37080(2006).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [22]
RP   INTERACTION WITH SCUBE3.
RX   PubMed=21441952; DOI=10.1038/onc.2011.85;
RA   Wu Y.Y., Peck K., Chang Y.L., Pan S.H., Cheng Y.F., Lin J.C., Yang R.B.,
RA   Hong T.M., Yang P.C.;
RT   "SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the
RT   epithelial-mesenchymal transition in lung cancer.";
RL   Oncogene 30:3682-3693(2011).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-548, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25893292; DOI=10.1038/onc.2015.100;
RA   Hwangbo C., Tae N., Lee S., Kim O., Park O.K., Kim J., Kwon S.H., Lee J.H.;
RT   "Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-
RT   to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I
RT   receptor internalization.";
RL   Oncogene 35:389-401(2016).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 38-159 IN COMPLEX WITH TGF-BETA3,
RP   AND DISULFIDE BONDS.
RX   PubMed=11850637; DOI=10.1038/nsb766;
RA   Hart P.J., Deep S., Taylor A.B., Shu Z., Hinck C.S., Hinck A.P.;
RT   "Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.";
RL   Nat. Struct. Biol. 9:203-208(2002).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) OF 49-159, AND DISULFIDE BONDS.
RX   PubMed=12121646; DOI=10.1016/s0969-2126(02)00780-3;
RA   Boesen C.C., Radaev S., Motyka S.A., Patamawenu A., Sun P.D.;
RT   "The 1.1 A crystal structure of human TGF-beta type II receptor ligand
RT   binding domain.";
RL   Structure 10:913-919(2002).
RN   [28]
RP   STRUCTURE BY NMR OF 38-159, AND DISULFIDE BONDS.
RX   PubMed=12939140; DOI=10.1021/bi034366a;
RA   Deep S., Walker K.P. III, Shu Z., Hinck A.P.;
RT   "Solution structure and backbone dynamics of the TGFbeta type II receptor
RT   extracellular domain.";
RL   Biochemistry 42:10126-10139(2003).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 43-149 IN COMPLEX WITH TGFBR1 AND
RP   TGFB3, AND DISULFIDE BONDS.
RX   PubMed=18243111; DOI=10.1016/j.molcel.2007.11.039;
RA   Groppe J., Hinck C.S., Samavarchi-Tehrani P., Zubieta C., Schuermann J.P.,
RA   Taylor A.B., Schwarz P.M., Wrana J.L., Hinck A.P.;
RT   "Cooperative assembly of TGF-beta superfamily signaling complexes is
RT   mediated by two disparate mechanisms and distinct modes of receptor
RT   binding.";
RL   Mol. Cell 29:157-168(2008).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 38-153 IN COMPLEX WITH TGFBR1 AND
RP   TGFB1, RECEPTOR AFFINITY FOR LIGANDS, AND DISULFIDE BONDS.
RX   PubMed=20207738; DOI=10.1074/jbc.m109.079921;
RA   Radaev S., Zou Z., Huang T., Lafer E.M., Hinck A.P., Sun P.D.;
RT   "Ternary complex of transforming growth factor-beta1 reveals isoform-
RT   specific ligand recognition and receptor recruitment in the superfamily.";
RL   J. Biol. Chem. 285:14806-14814(2010).
RN   [31]
RP   VARIANT HNPCC6 MET-315.
RX   PubMed=9590282; DOI=10.1038/ng0598-17;
RA   Lu S.-L., Kawabata M., Imamura T., Akiyama Y., Nomizu T., Miyazono K.,
RA   Yuasa Y.;
RT   "HNPCC associated with germline mutation in the TGF-beta type II receptor
RT   gene.";
RL   Nat. Genet. 19:17-18(1998).
RN   [32]
RP   VARIANT ESOPHAGEAL CANCER GLN-526.
RX   PubMed=10789724; DOI=10.1054/bjoc.1999.1178;
RA   Tanaka S., Mori M., Mafune K., Ohno S., Sugimachi K.;
RT   "A dominant negative mutation of transforming growth factor-beta receptor
RT   type II gene in microsatellite stable oesophageal carcinoma.";
RL   Br. J. Cancer 82:1557-1560(2000).
RN   [33]
RP   VARIANTS BREAST TUMOR MET-387; SER-435; ALA-447 AND MET-452, AND
RP   CHARACTERIZATION OF VARIANTS BREAST TUMOR SER-435; ALA-447 AND MET-452.
RX   PubMed=11212236;
RA   Luecke C.D., Philpott A., Metcalfe J.C., Thompson A.M., Hughes-Davies L.,
RA   Kemp P.R., Hesketh R.;
RT   "Inhibiting mutations in the transforming growth factor beta type 2
RT   receptor in recurrent human breast cancer.";
RL   Cancer Res. 61:482-485(2001).
RN   [34]
RP   VARIANT ILE-191.
RX   PubMed=12202987; DOI=10.1007/s100380200069;
RA   Watanabe Y., Kinoshita A., Yamada T., Ohta T., Kishino T., Matsumoto N.,
RA   Ishikawa M., Niikawa N., Yoshiura K.;
RT   "A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types
RT   of variations in genes for transforming growth factor-beta1 (TGF-beta1) and
RT   its signaling pathway.";
RL   J. Hum. Genet. 47:478-483(2002).
RN   [35]
RP   VARIANTS LDS2 PRO-308; PHE-449 AND CYS-537, AND CHARACTERIZATION OF
RP   VARIANTS LDS2 PRO-308; PHE-449 AND CYS-537.
RX   PubMed=15235604; DOI=10.1038/ng1392;
RA   Mizuguchi T., Collod-Beroud G., Akiyama T., Abifadel M., Harada N.,
RA   Morisaki T., Allard D., Varret M., Claustres M., Morisaki H., Ihara M.,
RA   Kinoshita A., Yoshiura K., Junien C., Kajii T., Jondeau G., Ohta T.,
RA   Kishino T., Furukawa Y., Nakamura Y., Niikawa N., Boileau C., Matsumoto N.;
RT   "Heterozygous TGFBR2 mutations in Marfan syndrome.";
RL   Nat. Genet. 36:855-860(2004).
RN   [36]
RP   VARIANTS LDS2 CYS-460 AND HIS-460.
RX   PubMed=16027248; DOI=10.1161/circulationaha.105.537340;
RA   Pannu H., Fadulu V.T., Chang J., Lafont A., Hasham S.N., Sparks E.,
RA   Giampietro P.F., Zaleski C., Estrera A.L., Safi H.J., Shete S.,
RA   Willing M.C., Raman C.S., Milewicz D.M.;
RT   "Mutations in transforming growth factor-beta receptor type II cause
RT   familial thoracic aortic aneurysms and dissections.";
RL   Circulation 112:513-520(2005).
RN   [37]
RP   VARIANTS LDS2 ASN-336; PRO-355; TRP-357; HIS-528 AND CYS-528.
RX   PubMed=15731757; DOI=10.1038/ng1511;
RA   Loeys B.L., Chen J., Neptune E.R., Judge D.P., Podowski M., Holm T.,
RA   Meyers J., Leitch C.C., Katsanis N., Sharifi N., Xu F.L., Myers L.A.,
RA   Spevak P.J., Cameron D.E., De Backer J.F., Hellemans J., Chen Y.,
RA   Davis E.C., Webb C.L., Kress W., Coucke P.J., Rifkin D.B., De Paepe A.M.,
RA   Dietz H.C.;
RT   "A syndrome of altered cardiovascular, craniofacial, neurocognitive and
RT   skeletal development caused by mutations in TGFBR1 or TGFBR2.";
RL   Nat. Genet. 37:275-281(2005).
RN   [38]
RP   VARIANT LDS2 ASN-446.
RX   PubMed=16251899; DOI=10.1038/sj.ejhg.5201502;
RA   Disabella E., Grasso M., Marziliano N., Ansaldi S., Lucchelli C., Porcu E.,
RA   Tagliani M., Pilotto A., Diegoli M., Lanzarini L., Malattia C.,
RA   Pelliccia A., Ficcadenti A., Gabrielli O., Arbustini E.;
RT   "Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not
RT   associated with FBN1 gene defects.";
RL   Eur. J. Hum. Genet. 14:34-38(2006).
RN   [39]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-73 AND HIS-528.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [40]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-61; ILE-191; MET-315; TYR-328; ILE-373;
RP   MET-387 AND SER-490.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [41]
RP   VARIANTS LDS2 HIS-190; VAL-247; PRO-325; ARG-357 AND ILE-530.
RX   PubMed=19533785; DOI=10.1002/ajmg.a.32918;
RA   Chung B.H., Lam S.T., Tong T.M., Li S.Y., Lun K.S., Chan D.H., Fok S.F.,
RA   Or J.S., Smith D.K., Yang W., Lau Y.L.;
RT   "Identification of novel FBN1 and TGFBR2 mutations in 65 probands with
RT   Marfan syndrome or Marfan-like phenotypes.";
RL   Am. J. Med. Genet. A 149A:1452-1459(2009).
RN   [42]
RP   VARIANT LDS2 SER-510.
RX   PubMed=19883511; DOI=10.1186/1750-1172-4-24;
RA   Drera B., Ritelli M., Zoppi N., Wischmeijer A., Gnoli M., Fattori R.,
RA   Calzavara-Pinton P.G., Barlati S., Colombi M.;
RT   "Loeys-Dietz syndrome type I and type II: clinical findings and novel
RT   mutations in two Italian patients.";
RL   Orphanet J. Rare Dis. 4:24-24(2009).
RN   [43]
RP   VARIANT LDS2 LYS-457.
RX   PubMed=20101701; DOI=10.1002/ajmg.a.33263;
RA   Muramatsu Y., Kosho T., Magota M., Yokotsuka T., Ito M., Yasuda A.,
RA   Kito O., Suzuki C., Nagata Y., Kawai S., Ikoma M., Hatano T., Nakayama M.,
RA   Kawamura R., Wakui K., Morisaki H., Morisaki T., Fukushima Y.;
RT   "Progressive aortic root and pulmonary artery aneurysms in a neonate with
RT   Loeys-Dietz syndrome type 1B.";
RL   Am. J. Med. Genet. A 152:417-421(2010).
RN   [44]
RP   VARIANTS LDS2 PRO-308 AND ARG-521.
RX   PubMed=20358619; DOI=10.1002/ajmg.a.33356;
RA   Kirmani S., Tebben P.J., Lteif A.N., Gordon D., Clarke B.L., Hefferan T.E.,
RA   Yaszemski M.J., McGrann P.S., Lindor N.M., Ellison J.W.;
RT   "Germline TGF-beta receptor mutations and skeletal fragility: a report on
RT   two patients with Loeys-Dietz syndrome.";
RL   Am. J. Med. Genet. A 152:1016-1019(2010).
RN   [45]
RP   VARIANTS LDS2 GLN-306 DELINS HIS-GLU; ARG-377; PHE-449 AND ARG-514.
RX   PubMed=22113417; DOI=10.1038/jhg.2011.130;
RA   Yang J.H., Ki C.S., Han H., Song B.G., Jang S.Y., Chung T.Y., Sung K.,
RA   Lee H.J., Kim D.K.;
RT   "Clinical features and genetic analysis of Korean patients with Loeys-Dietz
RT   syndrome.";
RL   J. Hum. Genet. 57:52-56(2012).
RN   [46]
RP   VARIANTS LDS2 VAL-509 AND PHE-510.
RX   PubMed=21949523; DOI=10.3345/kjp.2011.54.6.272;
RA   Ha J.S., Kim Y.H.;
RT   "A sporadic case of Loeys-Dietz syndrome type I with two novel mutations of
RT   the TGFBR2 gene.";
RL   Korean J. Pediatr. 54:272-275(2011).
CC   -!- FUNCTION: Has transforming growth factor beta-activated receptor
CC       activity. {ECO:0000269|PubMed:8635485}.
CC   -!- INTERACTION:
CC       P37173-2; P02750: LRG1; NbExp=3; IntAct=EBI-16065370, EBI-9083443;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=betaR-II {ECO:0000303|PubMed:8635485};
CC         IsoId=P37173-1; Sequence=Displayed;
CC       Name=2; Synonyms=betaR-IIB {ECO:0000303|PubMed:8635485};
CC         IsoId=P37173-2; Sequence=VSP_012157;
CC       Name=3; Synonyms=TbetaRII-SE {ECO:0000303|PubMed:34568316};
CC         IsoId=P37173-3; Sequence=VSP_061513, VSP_061514;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS33727.1; -.
DR   RefSeq; NP_001020018.1; NM_001024847.2.
DR   ProteomicsDB; 55265; -.
DR   Ensembl; ENST00000359013.4; ENSP00000351905.4; ENSG00000163513.19.
DR   Proteomes; UP000005640; Chromosome 3.
PE   1: Evidence at protein level;
SQ   SEQUENCE   592 AA;  67457 MW;  8ADCBA70F95E1CBB CRC64;
     MGRGLLRGLW PLHIVLWTRI ASTIPPHVQK SDVEMEAQKD EIICPSCNRT AHPLRHINND
     MIVTDNNGAV KFPQLCKFCD VRFSTCDNQK SCMSNCSITS ICEKPQEVCV AVWRKNDENI
     TLETVCHDPK LPYHDFILED AASPKCIMKE KKKPGETFFM CSCSSDECND NIIFSEEYNT
     SNPDLLLVIF QVTGISLLPP LGVAISVIII FYCYRVNRQQ KLSSTWETGK TRKLMEFSEH
     CAIILEDDRS DISSTCANNI NHNTELLPIE LDTLVGKGRF AEVYKAKLKQ NTSEQFETVA
     VKIFPYEEYA SWKTEKDIFS DINLKHENIL QFLTAEERKT ELGKQYWLIT AFHAKGNLQE
     YLTRHVISWE DLRKLGSSLA RGIAHLHSDH TPCGRPKMPI VHRDLKSSNI LVKNDLTCCL
     CDFGLSLRLD PTLSVDDLAN SGQVGTARYM APEVLESRMN LENVESFKQT DVYSMALVLW
     EMTSRCNAVG EVKDYEPPFG SKVREHPCVE SMKDNVLRDR GRPEIPSFWL NHQGIQMVCE
     TLTECWDHDP EARLTAQCVA ERFSELEHLD RLSGRSCSEE KIPEDGSLNT TK
//
